Regenerative Medical Technology Group Inc.
RMTG
$0.09
$0.00-4.44%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 52.41% | 67.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 52.41% | 67.91% | |||
| Cost of Revenue | 65.49% | 10.16% | |||
| Gross Profit | 45.95% | 126.62% | |||
| SG&A Expenses | 33.78% | 45.77% | |||
| Depreciation & Amortization | -7.06% | -0.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 43.70% | 28.17% | |||
| Operating Income | 135.18% | 186.27% | |||
| Income Before Tax | -231.56% | 37.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -231.56% | 37.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -231.56% | 37.08% | |||
| EBIT | 135.18% | 186.27% | |||
| EBITDA | 95.36% | 280.92% | |||
| EPS Basic | -229.39% | 38.13% | |||
| Normalized Basic EPS | -229.26% | 38.13% | |||
| EPS Diluted | -229.39% | 38.13% | |||
| Normalized Diluted EPS | -229.26% | 38.13% | |||
| Average Basic Shares Outstanding | 0.65% | 1.69% | |||
| Average Diluted Shares Outstanding | 0.65% | 1.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||